Sadler Diego, DeCara Jeanne M, Herrmann Joerg, Arnold Anita, Ghosh Arjun K, Abdel-Qadir Husam, Yang Eric H, Szmit Sebastian, Akhter Nausheen, Leja Monika, Silva Carolina Maria Pinto Domingues Carvalho, Raikhelkar Jayant, Brown Sherry-Ann, Dent Susan, O'Quinn Rupal, Thuny Franck, Moudgil Rohit, Raez Luis E, Okwuosa Tochukwu, Daniele Andres, Bauer Brenton, Kondapalli Lavanya, Ismail-Khan Roohi, Lax Jorge, Blaes Anne, Nahleh Zeina, Elson Leah, Baldassarre Lauren A, Zaha Vlad, Rao Vijay, Lara Daniel Sierra, Skurka Kerry
Heart and Vascular Center, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA.
University of Chicago, Chicago, USA.
Cardiooncology. 2020 Nov 27;6(1):28. doi: 10.1186/s40959-020-00085-5.
Re-allocation of resources during the COVID-19 pandemic has resulted in delays in care delivery to patients with cardiovascular disease and cancer. The ability of health care providers to provide optimal care in this setting has not been formally evaluated.
To assess the impact of COVID-19 resource re-allocation on scheduling, testing, elective procedures, telemedicine access, use of new COVID-19 therapies, and providers' opinions on healthcare policies among oncology and cardiology practitioners.
An electronic survey was conducted by a cardio-oncology collaborative network through regional and state chapters of the American College of Cardiology, American Society of Clinical Oncology, and the International Cardio-Oncology Society. Descriptive statistics were reported by frequency and proportion for analyses, and stratified categorically by geographic region and specialty.
One thousand four hundred fifteen providers (43 countries) participated: 986 cardiologists, 306 oncologists, and 118 trainees/internal medicine. 63% (195/306) of oncologists vs 92% (896/976) of cardiologists reported cancellations of treatments/elective procedures (p = 0.01). 46% (442/970) of cardiologists and 25% (76/303) of oncologists modified the scope of their practice (p = < 0.001). Academic physicians (74.5%) felt better supplied with personal protective equipment (PPE) vs non-academic (74.5% vs 67.2%; p = 0.018). Telemedicine was less common in Europe 81% (74/91), and Latin America 64% (101/158), than the United States, 88% (950/1097) (p = < 0.001). 95% of all groups supported more active leadership from medical professional societies.
These results support initiatives to promote expanded coverage for telemedicine, increased access to PPE, better testing availability and involvement of medical professional societies to help with preparedness for future health care crisis.
在新冠疫情期间，资源重新分配导致心血管疾病和癌症患者的护理服务延迟。医护人员在这种情况下提供最佳护理的能力尚未得到正式评估。
评估新冠疫情期间资源重新分配对肿瘤学和心脏病学从业者的排班、检测、择期手术、远程医疗接入、新型新冠治疗方法的使用以及他们对医疗政策的看法的影响。
一个心脏肿瘤协作网络通过美国心脏病学会、美国临床肿瘤学会和国际心脏肿瘤学会的地区和州分会进行了一项电子调查。分析采用频率和比例报告描述性统计数据，并按地理区域和专业进行分类分层。
1415名医护人员（来自43个国家）参与了调查：986名心脏病专家、306名肿瘤专家以及118名实习生/内科医生。63%（195/306）的肿瘤专家和92%（896/976）的心脏病专家报告称治疗/择期手术被取消（p = 0.01）。46%（442/970）的心脏病专家和25%（76/303）的肿瘤专家改变了他们的业务范围（p = < 0.001）。学术医生（74.5%）感觉个人防护装备（PPE）的供应比非学术医生更好（74.5%对67.2%；p = 0.018）。远程医疗在欧洲（81%，74/91）和拉丁美洲（64%，101/158）不如在美国常见（88%，950/1097）（p = < 0.001）。所有组中有95%支持医学专业协会发挥更积极的领导作用。
这些结果支持以下举措：促进扩大远程医疗覆盖范围、增加个人防护装备的可及性、提高检测的可用性以及医学专业协会的参与，以帮助应对未来的医疗危机。
